Verifying…
Home / Drug A–Z / Nkoyo Gentamicin Ear/Eye Drop

Nkoyo Gentamicin Ear/Eye Drop

NAFDAC Reg. No. 04-5510 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Nkoyo Gentamicin Ear/Eye Drop
NAFDAC number
04-5510
Active ingredient
Gentamicin (Gentamicin Sulfate)
Strength
0.3%
Form
Ear/eye drops
Pack size
1 x 5 mL (in plastic dropper bottle)
Manufacturer
Not listed
Applicant (holder)
Nkoyo Chemists Ltd
Approved
27 Jun 2024
Status
Active View on NAFDAC ↗
Registration valid to
26 Jun 2029
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Nkoyo Gentamicin Ear/Eye Drop is on the NAFDAC register with an active registration (04-5510). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Nkoyo Gentamicin Ear/Eye Drop

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: S Patients treated with aminoglycosides should be under close clinical observation because of the potential toxicity associated with their use. As with other aminoglycosides, gentamicin injection is potentially nephrotoxic. The risk of nephrotoxicity is greater in patients with impaired renal function and in those who receive high dosage of prolonged therapy. …
Who it is for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin injection and other antibacterial drugs, gentamicin injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. …

How to take it and how often
  • Gentamicin injection may be given IM or IV
  • The patient’s pretreatment body weight should be obtained for calculation of correct dosage
  • The dosage of aminoglycosides in obese patients should be based on an estimate of the lean body mass
  • It is desirable to limit the duration of treatment with aminoglycosides to short term
  • Patients with Normal Renal Function
  • Adults The recommended dosage of gentamicin injection for patients with serious infections and normal renal function is 3 mg/kg/day, administered in three equal doses every eight hours (Table 1)
  • For patients with life-threatening infections, dosages up to 5 mg/kg/day may be administered in three or four equal doses
  • This dosage should be reduced to 3 mg/kg/day as soon as clinically indicated (Table 1)
  • It is desirable to measure both peak and trough serum concentrations of gentamicin to determine the adequacy and safety of the dosage
  • When such measurements are feasible, they should be carried out periodically during therapy to assure adequate but not excessive drug levels
  • For example, the peak concentration (at 30 to 60 minutes after IM injection) is expected to be in the range of 4 to 6 mcg/mL
  • When monitoring peak concentrations after IM or IV administration, dosage should be adjusted so that prolonged levels above 12 mcg/mL are avoided
  • When monitoring trough concentrations (just prior to the next dose), dosage should be adjusted so that levels above 2 mcg/mL are avoided. …
While you are taking it
  • Patients should be counseled that antibacterial drugs including gentamicin injection should only be used to treat bacterial infections
  • They do not treat viral infections (e.g., the common cold)
  • When gentamicin injection is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. …
Talk to a doctor first if
  • Hypersensitivity to gentamicin is a contraindication to its use
  • A history of hypersensitivity or serious toxic reactions to other aminoglycosides may contraindicate use of gentamicin because of the known cross-sensitivity of patients to drugs in this class
Warnings

(See BOXED WARNINGS .) Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people. Aminoglycosides can cause fetal harm when administered to a pregnant woman. Aminoglycoside antibiotics cross the placenta, and there have been several reports of total irreversible bilateral congenital deafness in children whose mothers received streptomycin during pregnancy. …

Possible side effects

To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Nephrotoxicity Adverse renal effects, as demonstrated by the presence of casts, cells or protein in the urine or by rising BUN, NPN, serum creatinine or oliguria, have been reported. They occur more frequently in patients with a history of renal impairment (especially if dialysis is required) and in patients treated for longer periods or with larger doses than recommended. …

Pregnancy and breastfeeding

Pregnancy See WARNINGS section.

If you take too much

In the event of overdosage or toxic reactions, hemodialysis may aid in the removal of gentamicin from the blood, especially if renal function is, or becomes, compromised. The rate of removal of gentamicin is considerably lower by peritoneal dialysis than it is by hemodialysis.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2023-09-07.

Label for gentamicin (gentamicin sulfate), the active ingredient registered with NAFDAC.

Check your pack of Nkoyo Gentamicin Ear/Eye Drop

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Nkoyo Gentamicin Ear/Eye Drop

What is in Nkoyo Gentamicin Ear/Eye Drop?

Nkoyo Gentamicin Ear/Eye Drop contains Gentamicin (Gentamicin Sulfate) (0.3%), as ear/eye drops, according to its NAFDAC registration record.

Is Nkoyo Gentamicin Ear/Eye Drop registered with NAFDAC?

Yes. Nkoyo Gentamicin Ear/Eye Drop is listed on the NAFDAC register under registration number 04-5510, and its registration is active as of 28 October 2026.

Has Nkoyo Gentamicin Ear/Eye Drop been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Nkoyo Gentamicin Ear/Eye Drop in our automatically synced alert list.

How can I check that my pack of Nkoyo Gentamicin Ear/Eye Drop is genuine?

Run a free authenticity scan with the NAFDAC number 04-5510, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Nkoyo Gentamicin Ear/Eye Drop?

Follow your prescription or the leaflet in your pack. The official label says: Gentamicin injection may be given IM or IV. The patient’s pretreatment body weight should be obtained for calculation of correct dosage. The dosage of aminoglycosides in obese patients should be based on an estimate of the lean body mass. It is desirable to limit the duration of treatment with aminoglycosides to short term. Patients with Normal Renal Function Adults The recomme…

What is Nkoyo Gentamicin Ear/Eye Drop used for?

To reduce the development of drug-resistant bacteria and maintain the effectiveness of gentamicin injection and other antibacterial drugs, gentamicin injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying an (Summarised from the official U.S. FDA label for gentamicin (gentamicin sulfate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Nkoyo Gentamicin Ear/Eye Drop? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.